Modulation of lung molecular biomarkers by β-carotene in the physicians' health study

Cancer

Volumn 115, Issue 5, 2009, Pages 1049-1058

  Liu, Chun ^a   Wang, Xiang Dong ^a   Mucci, Lorelei ^b   Michael Gaziano, J ^b   Zhang, Shumin M ^b  

^a TUFTS UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

carotene; Lung cancer; Molecular markers; Proliferating cellular nuclear antigen

Indexed keywords

BETA CAROTENE; BIOLOGICAL MARKER; CYCLIN D1; CYCLINE; CYTOCHROME P450 1A1; PLACEBO; PROTEIN P53; RETINOIC ACID RECEPTOR BETA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL;

BETA CAROTENE; BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 61449210915     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24061     Document Type: Article

References (33)

1. Stahl W, Sies H. Bioactivity and protective effects of natural carotenoids. Biochim Biophys Acta. 2005;1740:101-107.
2. Mayne ST. Beta-carotene, carotenoids, and disease prevention in humans. FASEB J. 1996;10:690-701.
3. Mayne ST, Janerich DT, Greenwald P, et al. Dietary beta carotene and lung cancer risk in U.S. nonsmokers. J Natl Cancer Inst. 1994;86:33-38.
4. Michaud. DS, Feskanich D, Rimm EB, et al. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr. 2000;72:990-997.
5. Wright ME, Mayne ST, Swanson CA, Sinha R, Alavanja MC. Dietary carotenoids, vegetables, and lung cancer risk in women: the Missouri Women's Health Study (United States). Cancer Causes Control. 2003;14:85-96.
6. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
7. [Noauthors listed] The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994; 330:1029-1035.
8. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a. combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-1155.
9. Robles AI, Linke SP, Harris CC. The p53 network in lung carcinogenesis. Oncogene. 2002;21:6898-6907.
10. Wiethege T, Voss B, Muller KM. P53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer. J Cancer Res Clin Oncol. 1995;121:371-377.
11. Jetten AM, George MA, Pettit GR, Rearick JL Effects of bryostatins and retinoic acid on phorbol ester-and diacylglycerol-induced squamous differentiation in human tracheobronchial epithelial cells. Cancer Res. 1989;49:3990-3995.
12. Zhang XK, Liu, Y, Lee MO. Retinoid receptors in human lung cancer and breast cancer. Mutat Res. 1996;350:267-277.
13. Lotan R. Retinoids in cancer chemoprevention. FASEB J. 1996;10:1031-1039.
14. Guengerich FP, Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res. 1998;400:201-213.
15. Liu C, Russell RM, Wang XD. Exposing ferrets to cigarette smoke and a pharmacological dose of beta-carotene supplementation enhance in vitro retinoic acid catabolism in lungs via induction of cytochrome P450 enzymes. J Nutr. 2003;133:173-179.
16. Liu C, Wang XD, Bronson RT, Smith DE, Krinsky NI, Russell RM. Effects of physiological versus pharmacological beta-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smokeexposed ferrets. Carcinogenesis. 2000;21:2245-2253.
17. Liu, C, Russell RM, Wang XD. Low dose beta-carotene supplementation of ferrets attenuates smoke-induced lung phosphorylation of JNK, p38 MAPK, and p53 proteins. J Nutr. 2004;134:2705-2710.
18. Chung J, Liu, C, Smith DE, Seitz HK, Russell RM, Wang XD. Restoration of retinoic acid concentration suppresses ethanol-enhanced c-Jun expression and hepatocyte proliferation in rat liver. Carcinogenesis. 2001;22:1213-1219.
19. Saad RS, Liu Y, Han H, Landreneau RJ, Silverman JF. Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Mod Pathol. 2004;17:1235-1242.
20. Esposito V, Baldi A, De Luca A, et al. Cell cycle related proteins as prognostic parameters in radically resected nonsmall cell lung cancer. J Clin Pathol. 2005;58:734-739.
21. Chang YS, Chung JH, Shin DH, et al. Retinoic acid receptor-beta expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium. Yonsei Med J. 2004;45:435-442.
22. Chang JT, Chang H, Chen PH, Lin SL, Lin P. Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas. Clin Cancer Res. 2007;13:38-45.
23. Kim Y, Chongviriyaphan N, Liu C, Russell RM, Wang XD. Combined antioxidant (beta-carotene, alpha-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogenactivated protein kinase in the ferret lung cancer model. Carcinogenesis. 2006;27:1410-1419.
24. Zhang JY, Wang Y, Prakash C. Xenobiotic-metabolizing enzymes in human lung. Curr Drug Metab. 2006;7:939-948.
25. Paolini M, Antelli A, Pozzetti L, et al. Induction of cytochrome P450 enzymes and over-generation of oxygen radicals in beta-carotene supplemented, rats. Carcinogenesis. 2001;22:1483-1495.
26. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, Russell M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst. 1999;91:60-66.
27. Gradelet S, Ledere J, Siess MH, Astorg PO. Beta-apo-8′-carotenal, but not beta-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica. 1996;26:909-919.
28. Salgo MG, Cueto R, Winston GW, Pryor WA. Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radie Biol Med. 1999;26:162-173.
29. Xu XC, Sozzi G, Lee JS, et al. Suppression of retinoic acid receptor beta, in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst. 1997;89:624-629.
30. Houle B, Rochette-Egly C, Bradley WE. Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc Natl Acad Sci USA. 1993;90:985-989.
31. Mernitz H, Smith DE, Zhu AX, Wang XD. 9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2. Cancer Lett. 2006;244:101-108.
32. Kurie JM, Lotan R, Lee JJ, et al. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J Natl Cancer Inst. 2003;95:206-214.
33. Khuri FR, Lotan R, Kemp BL, et al. Retinoic add receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. J Clin Oncol. 2000;18:2798-2804.